JHEP Reports Internal Medicine
A novel preclinical platform to study FGFR2 fusion-driven cholangiocarcinoma☆
The publisher did not provide an abstract — full text is available via the link below.
JHEP Reports Internal Medicine
The publisher did not provide an abstract — full text is available via the link below.